← Open Payments lookup

RINA PATEL: Open Payments

NPI 1033664552 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,442 in 113 payments from 21 companies in 2025. Trend: 2023 $1,335 · 2024 $3,101 · 2025 $2,442

Food & beverage: $2,399Education: $43
CompanyPaymentsAmount
Salix Pharmaceuticals, a division of Bausch Health US, LLC19$382
ABBVIE INC.22$298
GENZYME CORPORATION8$237
Janssen Biotech, Inc.8$172
Lilly USA, LLC8$168
Celltrion USA Inc.7$138
Novo Nordisk Inc2$136
Regeneron Healthcare Solutions, Inc.4$133
QOL Medical, LLC5$131
ARS Pharmaceuticals Operations, Inc.1$124

Products named: DUPIXENT, XIFAXAN, TREMFYA, RINVOQ, OMVOH, VEGZELMA, Sucraid, NEFFY.

Industry payments across TX — which companies pay providers there.